GVRP (GV Research Platform), a Hyderabad-based research organisation, has announced the inauguration of the GVRP StepsBio Research Centre (GSRC), a collaboration with Steps Biosciences that marks a milestone in India's pharmaceutical R&D landscape.

Located within the 1BLR life sciences cluster Lifescapes in Bengaluru, the 15,000 sq. ft. facility is a dedicated Centre of Excellence for formulations research and development. GSRC represents GVRP's expansion into high-complexity formulations, an area increasingly central to the global drug development pipeline and further cements Bengaluru's emergence as a premier destination for life sciences innovation.

Purpose-built to address the most demanding formulation challenges, GSRC integrates advanced scientific infrastructure with specialised workflows to support complex drug delivery systems, sterile injectables and differentiated dosage forms. The centre also bridges with GVRP's established preclinical capabilities, enabling a truly integrated development continuum from molecule to formulated product under one collaborative ecosystem.

The launch of GSRC reflects a broader industry shift: as drug pipelines grow in complexity and the demand for precision therapeutics intensifies, the need for dedicated, high-calibre formulation infrastructure has never been greater. GSRC is positioned to meet this need head-on, offering pharmaceutical and biotechnology partners a differentiated scientific environment to accelerate the development of next-generation therapies.

Speaking about the significance of GSRC, the Founders said, Kalyan Korisapati, Co-Founder, GVRP, said, "The launch of GSRC is a defining moment in GVRP's evolution. Our Dedicated R&D Centres model has always been about building focused, best-in-class capabilities that serve the real needs of the industry and formulations is an area where that focus can unlock tremendous value. Through our collaboration with Steps Biosciences, we have created a facility that doesn't just meet today's R&D requirements, but is architected to scale alongside the evolving demands of global drug development. GSRC strengthens our ability to offer partners a truly integrated scientific platform from preclinical research through to complex formulation development and we believe it positions India as a serious destination for high-value pharmaceutical innovation."

Manoj Nerurkar, Founder, Steps Biosciences, said, "GSRC is the outcome of a shared conviction that world-class formulation science, enabled by the right infrastructure and the right technology, can fundamentally change how differentiated therapies are developed. At StepsBio, we are not only investing in physical infrastructure, but also in building AI-driven capabilities that will transform how we approach formulation design, predictive stability modelling and process optimisation. By integrating artificial intelligence into our scientific workflows at GSRC, we aim to dramatically reduce development timelines, improve decision-making at critical stages, and ultimately bring better therapies to patients faster. This facility is a statement of our long-term commitment to being at the frontier of formulation science combining deep domain expertise, cutting-edge infrastructure and the power of AI to deliver outcomes that were simply not possible before."

The facility is equipped with advanced formulation suites designed for the development of complex dosage forms, including liquid and lyophilized injectables, ophthalmic solutions and otic products. These sterile laboratories support controlled processing environments, aseptic operations and stringent material flow segregation, ensuring adherence to the highest quality and regulatory standards. Complementing these capabilities are dedicated pre-formulation and characterisation laboratories that enable comprehensive API characterisation, providing a strong scientific foundation for robust and predictable formulation development.

The centre also features an integrated analytical infrastructure comprising high-precision HPLC and UPLC systems, ICH-compliant stability chambers and specialised instruments for evaluating critical physical parameters such as particle size, rheology, viscosity and osmolality. This enables data-driven decision-making throughout the development lifecycle. In addition, StepsBio is actively incorporating artificial intelligence and machine learning capabilities within the GSRC to support predictive formulation design, accelerate screening workflows and enhance analytical interpretation, positioning the facility at the forefront of computational and experimental pharmaceutical science.

With the launch of GSRC, GVRP and StepsBio are making a joint statement about the future of pharmaceutical R&D in India, one defined by scientific ambition, strategic collaboration and a commitment to building capabilities that compete on the global stage. The centre is open to partnerships with pharmaceutical and biotechnology companies seeking to advance complex drug products with greater speed, precision, and scientific confidence.